A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease

The New York Times – Business:

The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.

Gina Kolata
Author: Gina Kolata

This post first appeared in The New York Times – Business. Read the original article.

Written by

Gina Kolata

in

, , ,

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts